BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35201567)

  • 1. LOC100130075 Promotes Cervical Cancer Progression by Activating MDM2 Transcription through E2F1.
    Xu Y; Liu Y; Huang W; Yang C; Wang Y
    Reprod Sci; 2022 May; 29(5):1439-1448. PubMed ID: 35201567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer.
    Ding X; Jia X; Wang C; Xu J; Gao SJ; Lu C
    Cell Death Differ; 2019 Sep; 26(9):1750-1765. PubMed ID: 30518908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional SNP in the MDM2 promoter mediates E2F1 affinity to modulate cyclin D1 expression in tumor cell proliferation.
    Yang ZH; Zhou CL; Zhu H; Li JH; He CD
    Asian Pac J Cancer Prev; 2014; 15(8):3817-23. PubMed ID: 24870800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
    Peng X; Zhang Y; Gao J; Cai C
    Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
    Tang Y; Dai G; Yang Y; Liu H
    J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
    Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
    Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway.
    Zhang Z; Wang H; Li M; Rayburn ER; Agrawal S; Zhang R
    Oncogene; 2005 Nov; 24(48):7238-47. PubMed ID: 16170383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
    Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
    Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer.
    Sun H; Xin J; Lu Z; Wang N; Liu N; Guo Q
    Cell Physiol Biochem; 2013; 32(5):1528-40. PubMed ID: 24335178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 inhibits MDM2 expression in a p53-dependent manner.
    Tian X; Chen Y; Hu W; Wu M
    Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
    Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
    Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
    Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
    Xu J; Xu W; Yang X; Liu Z; Sun Q
    Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.